放射相关miRNA在乳腺癌放疗中的作用

摘要/Abstract

摘要：

乳腺癌是女性最常见的肿瘤，而放疗是治疗乳腺癌的重要方法。放疗的效果很大程度上取决于肿瘤细胞的放射敏感性。微小RNA（miRNA）参与乳腺癌放疗反应的关键途径包括DNA损伤修复、凋亡、细胞周期停滞、自噬和相关信号通路。探讨miRNA在调节乳腺癌对放疗的治疗反应及其在相关信号通路中的作用，可为miRNA成为评估乳腺癌诊断、预后和放射疗效的指标提供参考。

关键词:乳腺肿瘤,微RNAs,辐射，电离

Abstract:

Breast cancer is the most common cancer in women, and radiotherapy is an important method of its treatment. The outcome of radiotherapy greatly depends on radiosensitivity of cancer cells. The key pathways of microRNAs （miRNAs） involved in breast cancer radiotherapy response include DNA damage repair, apoptosis, cell cycle arrest, autophagy and related signaling pathways. This article reviews the role of miRNAs in regulating the response of breast cancer to radiotherapy and related signaling pathways. To explore the role of miRNAs in regulating the treatment response of breast cancer to radiotherapy and related signaling pathways, it can provide reference for miRNAs to be used as an indicator to evaluate the diagnosis, prognosis and radiotherapy efficacy of breast cancer.

Key words:Breast neoplasms,MicroRNAs,Radiation, ionizing

金嘉会, 陈存海, 马学真. 放射相关miRNA在乳腺癌放疗中的作用[J]. 国际肿瘤学杂志, 2022, 49(12): 735-738.

Jin Jiahui, Chen Cunhai, Ma Xuezhen. Effects of radiation-associated miRNA in radiotherapy for breast cancer[J]. Journal of International Oncology, 2022, 49(12): 735-738.

参考文献35

[1]	Siegel RL, Miller KD, Fuchs HE, et al. Cancer statistics, 2021[J]. CA Cancer J Clin, 2021, 71(1): 7-33. DOI: 10.3322/caac.21654. doi:10.3322/caac.21654
[2]	中国抗癌协会乳腺癌专业委员会. 中国抗癌协会乳腺癌诊治指南与规范(2021年版)[J]. 中国癌症杂志, 2021, 31(10): 954-1040. DOI: 10.19401/j.cnki.1007-3639.2021.10.013. doi:10.19401/j.cnki.1007-3639.2021.10.013
[3]	Jarosz-Biej M, Smolarczyk R, Cichoń T, et al. Tumor microenviron-ment as a "game changer" in cancer radiotherapy[J]. Int J Mol Sci, 2019, 20(13): 3212. DOI: 10.3390/ijms20133212. doi:10.3390/ijms20133212
[4]	Cabrera-Licona A, Pérez-Añorve IX, Flores-Fortis M, et al. Decip-hering the epigenetic network in cancer radioresistance[J]. Radiother Oncol, 2021, 159: 48-59. DOI: 10.1016/j.radonc.2021.03.012. doi:10.1016/j.radonc.2021.03.012pmid:33741468
[5]	Qi X, Zhang DH, Wu N, et al. CeRNA in cancer: possible functions and clinical implications[J]. J Med Genet, 2015, 52(10): 710-718. DOI: 10.1136/jmedgenet-2015-103334. doi:10.1136/jmedgenet-2015-103334pmid:26358722
[6]	Scully R, Panday A, Elango R, et al. DNA double-strand break repair-pathway choice in somatic mammalian cells[J]. Nat Rev Mol Cell Biol, 2019, 20(11): 698-714. DOI: 10.1038/s41580-019-0152-0. doi:10.1038/s41580-019-0152-0
[7]	Tarsounas M, Sung P. The antitumorigenic roles of BRCA1-BARD1 in DNA repair and replication[J]. Nat Rev Mol Cell Biol, 2020, 21(5): 284-299. DOI: 10.1038/s41580-020-0218-z. doi:10.1038/s41580-020-0218-z
[8]	Tan X, Li Z, Ren S, et al. Dynamically decreased miR-671-5p exp-ression is associated with oncogenic transformation and radiochemo-resistance in breast cancer[J]. Breast Cancer Res, 2019, 21(1): 89. DOI: 10.1186/s13058-019-1173-5. doi:10.1186/s13058-019-1173-5
[9]	Wang B, Zheng J, Li R, et al. Long noncoding RNA LINC02582 acts downstream of miR-200c to promote radioresistance through CHK1 in breast cancer cells[J]. Cell Death Dis, 2019, 10(10): 764. DOI: 10.1038/s41419-019-1996-0. doi:10.1038/s41419-019-1996-0pmid:31601781
[10]	Pajic M, Froio D, Daly S, et al. miR-139-5p modulates radiothe-rapy resistance in breast cancer by repressing multiple gene networks of DNA repair and ROS defense[J]. Cancer Res, 2018, 78(2): 501-515. DOI: 10.1158/0008-5472.CAN-16-3105. doi:10.1158/0008-5472.CAN-16-3105
[11]	Icard P, Fournel L, Wu Z, et al. Interconnection between metabo-lism and cell cycle in cancer[J]. Trends Biochem Sci, 2019, 44(6): 490-501. DOI: 10.1016/j.tibs.2018.12.007. doi:10.1016/j.tibs.2018.12.007
[12]	吴儒星. miR-8069靶向作用CCND1增强三阴乳腺癌放射敏感性的研究[D]. 武汉: 华中科技大学, 2021. DOI: 10.27157/d.cnki.ghzku.2021.000001. doi:10.27157/d.cnki.ghzku.2021.000001
[13]	Zhang N, Zeng X, Sun C, et al. LncRNA LINC00963 promotes tumorigenesis and radioresistance in breast cancer by sponging miR-324-3p and inducing ACK1 expression[J]. Mol Ther Nucleic Acids, 2019, 18: 871-881. DOI: 10.1016/j.omtn.2019.09.033. doi:10.1016/j.omtn.2019.09.033
[14]	Ren YQ, Fu F, Han J. MiR-27a modulates radiosensitivity of triple-negative breast cancer (TNBC) cells by targeting CDC27[J]. Med Sci Monit, 2015, 21: 1297-1303. DOI: 10.12659/MSM.893974. doi:10.12659/MSM.893974
[15]	Mei Z, Su T, Ye J, et al. The miR-15 family enhances the radio-sensitivity of breast cancer cells by targeting G2 checkpoints[J]. Radiat Res, 2015, 183(2): 196-207. DOI: 10.1667/RR13784.1. doi:10.1667/RR13784.1
[16]	Zhang X, Li Y, Wang D, et al. miR-22 suppresses tumorigenesis and improves radiosensitivity of breast cancer cells by targeting Sirt1[J]. Biol Res, 2017, 50(1): 27. DOI: 10.1186/s40659-017-0133-8. doi:10.1186/s40659-017-0133-8pmid:28882183
[17]	Kong D, Shen D, Liu Z, et al. Circ_0008500 knockdown improves radiosensitivity and inhibits tumorigenesis in breast cancer through the miR-758-3p/PFN2 axis[J]. J Mammary Gland Biol Neoplasia, 2022, 27(1): 37-52. DOI: 10.1007/s10911-022-09514-w. doi:10.1007/s10911-022-09514-w
[18]	Wu J, Sun Z, Sun H, et al. MicroRNA-27a promotes tumorige-nesis via targeting AKT in triple negative breast cancer[J]. Mol Med Rep, 2018, 17(1): 562-570. DOI: 10.3892/mmr.2017.7886. doi:10.3892/mmr.2017.7886
[19]	Ma Y, Yu L, Yan W, et al. lncRNA GAS5 sensitizes breast cancer cells to ionizing radiation by inhibiting DNA repair[J]. Biomed Res Int, 2022, 2022: 1987519. DOI: 10.1155/2022/1987519. doi:10.1155/2022/1987519
[20]	Cao K, Tait SWG. Apoptosis and cancer: force awakens, phantom menace, or both?[J]. Int Rev Cell Mol Biol, 2018, 337: 135-152. DOI: 10.1016/bs.ircmb.2017.12.003. doi:S1937-6448(17)30101-6pmid:29551159
[21]	Lai Y, Chen Y, Lin Y, et al. Down-regulation of lncRNA CCAT1 enhances radiosensitivity via regulating miR-148b in breast cancer[J]. Cell Biol Int, 2018, 42(2): 227-236. DOI: 10.1002/cbin.10890. doi:10.1002/cbin.10890pmid:29024383
[22]	Fu Y, Xiong J. MicroRNA-124 enhances response to radiotherapy in human epidermal growth factor receptor 2-positive breast cancer cells by targeting signal transducer and activator of transcription 3[J]. Croat Med J, 2016, 57(5): 457-464. DOI: 10.3325/cmj.2016.57.457. doi:10.3325/cmj.2016.57.457pmid:27815936
[23]	Yang B, Kuai F, Chen Z, et al. miR-634 decreases the radioresis-tance of human breast cancer cells by targeting STAT3[J]. Cancer Biother Radiopharm, 2020, 35(3): 241-248. DOI: 10.1089/cbr.2019.3220. doi:10.1089/cbr.2019.3220
[24]	Li X, He S, Ma B. Autophagy and autophagy-related proteins in cancer[J]. Mol Cancer, 2020, 19(1): 12. DOI: 10.1186/s12943-020-1138-4. doi:10.1186/s12943-020-1138-4pmid:31969156
[25]	Meng C, Liu Y, Shen Y, et al. MicroRNA-26b suppresses auto-phagy in breast cancer cells by targeting DRAM1 mRNA, and is downregulated by irradiation[J]. Oncol Lett, 2018, 15(2): 1435-1440. DOI: 10.3892/ol.2017.7452. doi:10.3892/ol.2017.7452
[26]	Luo J, Chen J, He L. MiR-129-5p attenuates irradiation-induced autophagy and decreases radioresistance of breast cancer cells by targeting HMGB1[J]. Med Sci Monit, 2015, 21: 4122-4129. DOI: 10.12659/msm.896661. doi:10.12659/msm.896661
[27]	Sun Q, Liu T, Yuan Y, et al. MiR-200c inhibits autophagy and enhances radiosensitivity in breast cancer cells by targeting UBQLN1[J]. Int J Cancer, 2015, 136(5): 1003-1012. DOI: 10.1002/ijc.29065. doi:10.1002/ijc.29065pmid:25044403
[28]	Gomes LR, Menck CFM, Leandro GS. Autophagy roles in the modulation of DNA repair pathways[J]. Int J Mol Sci, 2017, 18(11): 2351. DOI: 10.3390/ijms18112351. doi:10.3390/ijms18112351
[29]	Tang D, Kang R, Livesey KM, et al. Endogenous HMGB1 regulates autophagy[J]. J Cell Biol, 2010, 190(5): 881-892. DOI: 10.1083/jcb.200911078. doi:10.1083/jcb.200911078pmid:20819940
[30]	Sun H, Ding C, Zhang H, et al. Let-7 miRNAs sensitize breast cancer stem cells to radiation-induced repression through inhibition of the cyclin D1/Akt1/Wnt1 signaling pathway[J]. Mol Med Rep, 2016, 14(4): 3285-3292. DOI: 10.3892/mmr.2016.5656. doi:10.3892/mmr.2016.5656
[31]	Hong SE, Jin HO, Kim SM, et al. miR-3188 enhances sensitivity of breast cancer cells to ionizing radiation by down-regulating rictor[J]. Anticancer Res, 2021, 41(12): 6169-6176. DOI: 10.21873/anticanres.15436. doi:10.21873/anticanres.15436
[32]	Yu L, Yang Y, Hou J, et al. MicroRNA-144 affects radiotherapy sensitivity by promoting proliferation, migration and invasion of breast cancer cells[J]. Oncol Rep, 2015, 34(4): 1845-1852. DOI: 10.3892/or.2015.4173. doi:10.3892/or.2015.4173pmid:26252024
[33]	Metheetrairut C, Adams BD, Nallur S, et al. Cel-miR-237 and its homologue, hsa-miR-125b, modulate the cellular response to ionizing radiation[J]. Oncogene, 2017, 36(4): 512-524. DOI: 10.1038/onc.2016.222. doi:10.1038/onc.2016.222pmid:27321180
[34]	Lee HC, Her NG, Kang D, et al. Radiation-inducible miR-770-5p sensitizes tumors to radiation through direct targeting of PDZ-binding kinase[J]. Cell Death Dis, 2017, 8(3): e2693. DOI: 10.1038/cddis.2017.116. doi:10.1038/cddis.2017.116
[35]	Luo M, Ding L, Li Q, et al. MiR-668 enhances the radioresistance of human breast cancer cell by targeting IκBα[J]. Breast Cancer, 2017, 24(5): 673-682. DOI: 10.1007/s12282-017-0756-1. doi:10.1007/s12282-017-0756-1pmid:28138801